MIR4470

Across TCGA pan-cancer cohorts, MIR4470 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of MIR4470’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR4470 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4470 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

STAD, BLCA, and KIRP are the cancer types where MIR4470 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4470 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.380	.007	4	view →
BLCA	All	III,IV	+0.277	.036	3	view →
KIRP	All	II,III,IV	+0.437	.032	2	view →
KIRC	All	All	+0.129	.031	2	view →
COAD	Male	IV	+0.684	.049	1	view →
LUSC	Male	All	+0.249	.030	1	view →
THCA	All	All	−0.155	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

MIR4470–STAD

Open the STAD breakdown →